Literature DB >> 8382111

Aberrations of p53 gene in human hepatocellular carcinoma from China.

D Li1, Y Cao, L He, N J Wang, J R Gu.   

Abstract

Allele losses and mutations have been examined in 38 cases of primary hepatocellular carcinomas (HCC) from different geographic areas of China by Southern, single-strand conformational polymorphism (SSCP) and direct DNA sequencing analyses. Two of 12 samples from Qi-Dong and six of 18 HCCs from Shanghai showed loss of heterozygosity (LOH) at the loci on chromosome 17p13.3. All of the nine mutations in the p53 gene detected in HCC from Qi-Dong were clustered at the third base of codon 249, i.e. G:C to T:A, leading to an arginine to serine change. In contrast, 18 HCC samples from Shanghai contained three mutations at codons 249, 255 and 279. These results suggested a relationship between the spectrum of p53 aberration and environmental risk factors in these two geographic areas. Since no correlation between the state of HBV DNA and p53 aberration was observed, other factors such as dietary exposure to aflatoxin B1 (AFB1) might be responsible for the mutational hotspot at codon 249 in HCCs from Qi-Dong area.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8382111     DOI: 10.1093/carcin/14.2.169

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  21 in total

1.  Aflatoxin sufferer and p53 gene mutation in hepatocellular carcinoma.

Authors:  Zhuo-Lin Deng; Yun Ma
Journal:  World J Gastroenterol       Date:  1998-02       Impact factor: 5.742

2.  Assessment of the Proliferative Marker Ki-67 and p53 Protein Expression in HBV- and HCV-related Hepatocellular Carcinoma Cases in Egypt.

Authors:  Waleed S Mohamed; Masoud M Omar; Tarek M Khayri; Ibrahim M Fakhr
Journal:  Int J Health Sci (Qassim)       Date:  2008-01

Review 3.  The Molecular Basis of Toxins' Interactions with Intracellular Signaling via Discrete Portals.

Authors:  Adi Lahiani; Ephraim Yavin; Philip Lazarovici
Journal:  Toxins (Basel)       Date:  2017-03-16       Impact factor: 4.546

4.  Codon 249 mutation in exon 7 of p53 gene in plasma DNA: maybe a new early diagnostic marker of hepatocellular carcinoma in Qidong risk area, China.

Authors:  Xing-Hua Huang; Lu-Hong Sun; Dong-Dong Lu; Yan Sun; Li-Jie Ma; Xi-Ran Zhang; Jian Huang; Long Yu
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

5.  Aflatoxin B1 induces the transversion of G-->T in codon 249 of the p53 tumor suppressor gene in human hepatocytes.

Authors:  F Aguilar; S P Hussain; P Cerutti
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

6.  Genetic heterogeneity of hepatocellular carcinoma.

Authors:  H Unsal; C Yakicier; C Marçais; M Kew; M Volkmann; H Zentgraf; K J Isselbacher; M Ozturk
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

7.  Allelic imbalance regions on chromosomes 8p, 17p and 19p related to metastasis of hepatocellular carcinoma: comparison between matched primary and metastatic lesions in 22 patients by genome-wide microsatellite analysis.

Authors:  Lian-Hai Zhang; Lun-Xiu Qin; Zeng-Chen Ma; Sheng-Long Ye; Yin-Kun Liu; Qing-Hai Ye; Xin Wu; Wei Huang; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2003-05-07       Impact factor: 4.553

Review 8.  Hypoxia inducible factor in hepatocellular carcinoma: A therapeutic target.

Authors:  Daniel Lin; Jennifer Wu
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

9.  Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1.

Authors:  K A McGlynn; E A Rosvold; E D Lustbader; Y Hu; M L Clapper; T Zhou; C P Wild; X L Xia; A Baffoe-Bonnie; D Ofori-Adjei
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

Review 10.  p53 mutations as fingerprints for aristolochic acid: an environmental carcinogen in endemic (Balkan) nephropathy.

Authors:  Neda Slade; Ute M Moll; Branko Brdar; Arijana Zorić; Bojan Jelaković
Journal:  Mutat Res       Date:  2009-02-04       Impact factor: 2.433

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.